Novartis Pharmaceuticals

1 recall on record · Last recall: Aug 4, 2026

Read the history in context

Records, not a safety rating.

Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.

View source coverage →

Severity Breakdown

Class I — Serious

Class II — Moderate

Class III — Low Risk

Recall Timeline

Class IIFDAAug 4, 2026

Novartis Pharmaceuticals — Failed Dissolution Specifications

Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34 Failed Dissolution Specifications

Track Novartis Pharmaceuticals recalls automatically

Get an alert when a matching Novartis Pharmaceuticals recall turns up.

Start Free Trial